Fierce Pharma August 3, 2023
The FDA and the Drug Enforcement Administration (DEA) are urging manufacturers to boost production of prescription stimulants as the shortage of drugs such as Adderall approaches the one-year mark.
In a joint letter signed by FDA Commissioner Robert Califf, M.D., and DEA Administrator Anne Milgram, the two officials said their agencies are working with manufacturers and other stakeholders in the supply chain to alleviate the current shortage and take steps to prevent future shortages.
“This is not a problem that the FDA and DEA can solve on our own (and) we have called on manufacturers to confirm they are working to increase production to meet their allotted quota amount,” the letter said.
Among the causes of the...
Today's Sponsors
Today's Sponsor